The second-generation(atypical)antipsychotic of Blonanserin has high affinity for dopamine D2,D3 and 5 Hydroxytryptamine 2A receptor(5-HT2 A)receptors and lower affinity for adrenergic α1,5-HT2C,histamine H1,muscarinic M1 and muscarinic M3.More than a decade of clinical research has shown that:Blonanserin not only has a good effect on positive and negative symptoms of schizophrenia,but also has an anti-anxiety and anti-depression effect,and has a good effect on patients'cognition and social function.